You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

108 search results for: chronic inflammation

Role of Type 2 <b>Inflammation</b> Across Different <b>Chronic</b> Diseases

expert video

Role of Type 2 Inflammation Across Different Chronic Diseases

36 min

Type 2 Inflammation

Profs. Oscar Palomares, Stephan Weidinger, Valerie Lund, and Ulrike von Arnim highlight how underlying type 2 inflammation contributes to key symptoms of inflammatory diseases across organs

videoanimation

Pathways to Disease: Inflammation in Chronic Obstructive Pulmonary Disease Video

4 min

Pulmonology

Learn about the significant burden that patients with COPD experience and the role of inflammatory mechanisms in this chronic, often progressive disease.

<b>Chronic</b> Type 2 <b>Inflammation</b> Causes Loss of Smell in CRSwNP

expert video

Chronic Type 2 Inflammation Causes Loss of Smell in CRSwNP

4 min

Rhinology

Prof. Wytske Fokkens discusses how chronic type 2 inflammation leads to loss of smell in patients with CRSwNP.

The Role of <b>Chronic</b> <b>Inflammation</b> in the Pathogenesis of CSU

expert video

The Role of Chronic Inflammation in the Pathogenesis of CSU

10 min

Dermatology

Drs. Kim and Saini discuss the role of chronic inflammation in the pathogenesis of CSU in this insightful interview.

Connecting the Dots from Type 2 <b>Inflammation</b> to Patient Perspectives

expert video

Connecting the Dots from Type 2 Inflammation to Patient Perspectives

4 min

Type 2 Inflammation

Learn the connection between chronic type 2 inflammation, symptoms, and impact on quality of life in diseases with underlying type 2 inflammation

Pathways to Disease: <b>Inflammation</b> in COPD

interactivity

Pathways to Disease: Inflammation in COPD

5 min

Pulmonology

Learn about the pathophysiology of COPD and the involvement of chronic inflammation on the airways

Type 2 <b>Inflammation</b>, Neurosensitization, and <b>Chronic</b> Itch in Atopic Dermatitis

interactivity

Type 2 Inflammation, Neurosensitization, and Chronic Itch in Atopic Dermatitis

10 min

Dermatology

Learn about type 2 inflammation as a driver of neurosensitization and chronic itch in atopic dermatitis with this educational tool.

Type 2 <b>Inflammation</b> and <b>Chronic</b> Pruritus in AD and PN

expert video

Type 2 Inflammation and Chronic Pruritus in AD and PN

7 min

Dermatology

Highlights from the ADVENT symposium at AAD 2023 on the shared and unique roles of type 2 inflammation in atopic dermatitis and prurigo nodularis.

The Role of Type 2 <b>Inflammation</b> in <b>Chronic</b> Spontaneous Urticaria (CSU)

Infographic

The Role of Type 2 Inflammation in Chronic Spontaneous Urticaria (CSU)

5 min

Dermatology

A summary infographic capturing how type 2 inflammation contributes to pathological processes leading to CSU signs and symptoms.

expert video

A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in Prurigo Nodularis and Chronic Spontaneous Urticaria

45 min

Dermatology

Dr. Elmariah, Professor Metz, and Dr. Kim discuss the unique clinical presentations of PN and CSU and explore the shared and distinct pathophysiological underpinnings of itch and inflammation in both diseases, with a focus on the roles of type 2 cytokines at the neuroimmune axis In PN and CSU.

Role of Type 2 <b>Inflammation</b> in <b>Chronic</b> Inflammatory Diseases

expert video

Role of Type 2 Inflammation in Chronic Inflammatory Diseases

15 min

Dermatology

Type 2 inflammatory mechanisms and key type 2 cytokines in the pathogenesis of atopic dermatitis – Presentation from the ADVENT symposium at ISID 2023

The Heterogeneity of Underlying <b>Inflammation</b> in Patients With COPD

expert video

The Heterogeneity of Underlying Inflammation in Patients With COPD

2 min

Pulmonology

Join global expert Professor Ian Pavord as he discusses the heterogeneity of underlying inflammation in patients with COPD.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region